R. Petter Tonseth

450 total citations
21 papers, 189 citations indexed

About

R. Petter Tonseth is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, R. Petter Tonseth has authored 21 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Neurology. Recurrent topics in R. Petter Tonseth's work include Lymphoma Diagnosis and Treatment (15 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Treatments and Mutations (6 papers). R. Petter Tonseth is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Lung Cancer Treatments and Mutations (6 papers). R. Petter Tonseth collaborates with scholars based in Canada and Denmark. R. Petter Tonseth's co-authors include Kerry J. Savage, Laurie H. Sehn, Diego Villa, Graham W. Slack, Alina S. Gerrie, David W. Scott, Joseph M. Connors, Tom Pickles, Pedro Farinha and Ciara L. Freeman and has published in prestigious journals such as Blood, British Journal of Haematology and Cancers.

In The Last Decade

R. Petter Tonseth

14 papers receiving 185 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Petter Tonseth Canada 9 134 72 71 68 58 21 189
Isabel Alvarez Italy 4 137 1.0× 54 0.8× 69 1.0× 46 0.7× 30 0.5× 7 157
Jasmin Mettler Germany 7 174 1.3× 41 0.6× 43 0.6× 133 2.0× 73 1.3× 15 218
G. Mikhaeel United Kingdom 5 136 1.0× 34 0.5× 48 0.7× 101 1.5× 75 1.3× 18 175
Christian Berdel Germany 5 65 0.5× 52 0.7× 40 0.6× 16 0.2× 22 0.4× 8 127
Sabine Balmer Majno Switzerland 7 53 0.4× 85 1.2× 51 0.7× 59 0.9× 99 1.7× 12 299
Maja Bech Juul Denmark 5 167 1.2× 95 1.3× 66 0.9× 8 0.1× 22 0.4× 11 208
Kelly Cozens United Kingdom 4 67 0.5× 35 0.5× 21 0.3× 49 0.7× 66 1.1× 11 122
Kristina Sonnevi Sweden 10 99 0.7× 79 1.1× 21 0.3× 8 0.1× 22 0.4× 25 177
Franz Herrmann Germany 4 169 1.3× 39 0.5× 46 0.6× 170 2.5× 96 1.7× 7 262
Angela Giovanna Congiu Italy 6 63 0.5× 52 0.7× 28 0.4× 34 0.5× 23 0.4× 18 149

Countries citing papers authored by R. Petter Tonseth

Since Specialization
Citations

This map shows the geographic impact of R. Petter Tonseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Petter Tonseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Petter Tonseth more than expected).

Fields of papers citing papers by R. Petter Tonseth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Petter Tonseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Petter Tonseth. The network helps show where R. Petter Tonseth may publish in the future.

Co-authorship network of co-authors of R. Petter Tonseth

This figure shows the co-authorship network connecting the top 25 collaborators of R. Petter Tonseth. A scholar is included among the top collaborators of R. Petter Tonseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Petter Tonseth. R. Petter Tonseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yousefirizi, Fereshteh, Ivan S. Klyuzhin, R. Petter Tonseth, et al.. (2024). Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma. Cancers. 16(6). 1090–1090. 13 indexed citations
3.
4.
Villa, Diego, R. Petter Tonseth, Alina S. Gerrie, et al.. (2024). Long‐term follow‐up of bulky classic Hodgkin lymphoma managed with ABVD and PET‐guided RT demonstrates excellent outcomes in PET‐negative cases. British Journal of Haematology. 206(1). 167–171.
5.
Villa, Diego, Jean-François Larouche, Matthew C. Cheung, et al.. (2023). Rituximab combined with chemotherapy and acalabrutinib prior to autologous stem cell transplantation in mantle cell lymphoma: The Rectangle Trial. Hematological Oncology. 41(S2). 483–484.
6.
Villa, Diego, Jean-François Larouche, Matthew C. Cheung, et al.. (2023). Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial. Blood. 142(Supplement 1). 3042–3042.
7.
Villa, Diego, R. Petter Tonseth, Alina S. Gerrie, et al.. (2023). HL-353 Long-Term Outcomes of Bulky Classic Hodgkin Lymphoma Managed With a Positron Emission Tomography (PET)-Adapted Approach Demonstrate Excellent Outcomes in PET-Negative Cases. Clinical Lymphoma Myeloma & Leukemia. 23. S411–S411.
8.
Villa, Diego, R. Petter Tonseth, David W. Scott, et al.. (2021). Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach. Blood Advances. 5(18). 3647–3655. 4 indexed citations
9.
Hayden, Anna, R. Petter Tonseth, Diego Villa, et al.. (2020). Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach. Blood. 136(24). 2803–2811. 42 indexed citations
10.
Freeman, Ciara L., Kerry J. Savage, Diego Villa, et al.. (2020). Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP. Blood. 137(7). 929–938. 48 indexed citations
11.
Villa, Diego, R. Petter Tonseth, David W. Scott, et al.. (2019). Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach. Blood. 134(Supplement_1). 2845–2845.
12.
Hayden, Anna, R. Petter Tonseth, Diego Villa, et al.. (2019). OUTCOME OF PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA IN THE RITUXIMAB ERA: IMPACT OF A PET‐GUIDED APPROACH. Hematological Oncology. 37(S2). 156–157.
13.
Sehn, Laurie H., David W. Scott, Diego Villa, et al.. (2019). Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC). Blood. 134(Supplement_1). 401–401. 11 indexed citations
14.
Lum, Julian J., et al.. (2017). Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report. Journal of Gastrointestinal Oncology. 8(6). E84–E89. 10 indexed citations
15.
Feng, Xiaolan, Tanya Berrang, John Paul McGhie, et al.. (2017). Acute Inflammatory Response During Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Case Report. Cureus. 9(6). e1332–e1332. 1 indexed citations
16.
17.
Freeman, Ciara L., Kerry J. Savage, Diego Villa, et al.. (2017). Long-Term Results of PET-Guided Radiation Therapy in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma Treated with R-CHOP in British Columbia. Blood. 130(Suppl_1). 823–823. 6 indexed citations
18.
Darras, Kathryn E., David K. Tso, Teresa Liang, et al.. (2017). Development of an Undergraduate Radiology Curriculum: Ten-Year Experience from the University of British Columbia. Canadian Association of Radiologists Journal. 68(3). 237–242. 8 indexed citations
19.
Weber, Britta, Mitchell Liu, Stephan W. Morris, et al.. (2015). Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion‐positive lung cancer patient. Journal of Medical Radiation Sciences. 63(1). 67–70. 8 indexed citations
20.
Sehn, Laurie H., Karamjit Gill, Abdulwahab J. Al-Tourah, et al.. (2014). Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC). Blood. 124(21). 392–392. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Alvarez Breakdown of academic impact, for papers by Jasmin Mettler Breakdown of academic impact, for papers by G. Mikhaeel Breakdown of academic impact, for papers by Christian Berdel Breakdown of academic impact, for papers by Sabine Balmer Majno Breakdown of academic impact, for papers by Maja Bech Juul Breakdown of academic impact, for papers by Kelly Cozens Breakdown of academic impact, for papers by Kristina Sonnevi Breakdown of academic impact, for papers by Franz Herrmann Breakdown of academic impact, for papers by Angela Giovanna Congiu
Rankless by CCL
2026